Otros idiomas Sensus Healthcare, Inc.

Acciones

SRTS

US81728J1097

Mercado cerrado - Nasdaq Otros sitios de cotización 22:30:00 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
3,65 ^USD	-5,44 %		+7,04 %	+54,66 %

08/02	Transcript : Sensus Healthcare, Inc., Q4 2023 Earnings Call, Feb 08, 2024
08/02	Sensus Healthcare, Inc. presenta los resultados del cuarto trimestre y del ejercicio finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024	25/04
Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024	25/04
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024	18/04
Sensus Healthcare to Participate in the 36th Annual Roth Conference	14/03
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting	13/03
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting	13/03
Sensus Healthcare, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08/02
Earnings Flash (SRTS) SENSUS HEALTHCARE Posts Q4 Revenue $12.6M, vs. Street Est of $12.1M	08/02
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results	08/02
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities	08/02
Sensus Healthcare Issued U.S. Patent for SRT-100 Vision® System (IG-SRT) Capabilities	08/02
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements	06/02
Sensus Healthcare Collaborates with CureRays to Provide Oversight to Help Customers Assure Patient Safety, Reliability of Outcomes and Conformance with Regulatory Requirements	06/02
Sensus Healthcare Announces Retirement of Director Samuel O’Rear	01/02
Sensus Healthcare Announces Directors Changes	01/02
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024	30/01
Sensus Healthcare to Host Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call on Thursday, February 8, 2024	30/01
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million	23/01
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million	23/01
Sensus Healthcare, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	23/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Sensus Healthcare, Inc.

Acciones

SRTS

US81728J1097

Otros idiomas

Filtros